Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nothing in this 10Q that should have initiated the restriction

"I actually think that IMO the (5?) licensees in Feb were also contingency arrangements (the contracting precedent having been established with the Js), and that's why all the goofiness about that."

 

 

Remember the T3 suit and what they stated. I think they are looking for tranparency in negoiations. Perhaps so is everyone else now also.

Share
New Message
Please login to post a reply